Cari-Med Limited, a leading name in the pharmaceutical and healthcare industry, is headquartered in Jamaica (JM) and operates extensively across the Caribbean region. Founded in 1993, the company has established itself as a trusted provider of high-quality medical products and services, focusing on pharmaceuticals, consumer health, and medical devices. With a commitment to innovation and excellence, Cari-Med Limited offers a diverse range of core products, including prescription medications and over-the-counter solutions, distinguished by their adherence to international quality standards. The company has achieved significant milestones, positioning itself as a key player in the market, known for its robust distribution network and strategic partnerships. Cari-Med Limited continues to enhance healthcare accessibility and improve patient outcomes across the Caribbean, solidifying its reputation as a reliable partner in health.
How does Cari-Med Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cari-Med Limited's score of 10 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cari-Med Limited, headquartered in Jamaica (JM), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cari-Med Limited may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As such, the company appears to be in the early stages of addressing its climate impact, with no emissions inherited from a parent organization or cascaded targets from a corporate family.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cari-Med Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.